Title : A NOS3 polymorphism determines endothelial response to folate in children with type 1 diabetes or obesity.

Pub. Date : 2015 Feb

PMID : 25477161






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A NOS3 polymorphism determines endothelial response to folate in children with type 1 diabetes or obesity. Folic Acid nitric oxide synthase 3 Homo sapiens
2 OBJECTIVE: To determine the effect of polymorphisms in NOS3 and folate pathway enzymes on vascular function and folate status and endothelial response to folate in children with diabetes or obesity. Folic Acid nitric oxide synthase 3 Homo sapiens
3 OBJECTIVE: To determine the effect of polymorphisms in NOS3 and folate pathway enzymes on vascular function and folate status and endothelial response to folate in children with diabetes or obesity. Folic Acid nitric oxide synthase 3 Homo sapiens
4 The effect of NOS3 genotype on endothelial response to folate (5 mg) was assessed in 85 subjects with diabetes and 28 obese subjects who received active treatment during intervention trials. Folic Acid nitric oxide synthase 3 Homo sapiens
5 The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 +- 5% (insertion carriers) vs 2.3 +- 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 +- 5.4% (insertion carriers) and deteriorated by -3.2 +- 7.2% (deletion carriers), P = .05. Folic Acid nitric oxide synthase 3 Homo sapiens
6 CONCLUSIONS: A NOS3 polymorphism predicts endothelial response to folate in children with diabetes or obesity, with implications for vascular risk and folate intervention studies. Folic Acid nitric oxide synthase 3 Homo sapiens
7 CONCLUSIONS: A NOS3 polymorphism predicts endothelial response to folate in children with diabetes or obesity, with implications for vascular risk and folate intervention studies. Folic Acid nitric oxide synthase 3 Homo sapiens